Wyden Statement on Economic Analysis of NAFTA Update

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement on the International Trade Commission’s economic analysis of the updated NAFTA trade deal: “This report confirms what has been clear since this deal was announced – Donald Trump’s NAFTA represents at best a minor update to NAFTA, which will offer only limited […]

Wyden, Cardin Introduce Legislation to Protect Taxpayers From Fraud

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and Senator Ben Cardin, D-Md., today introduced legislation to allow the IRS to require minimum standards for paid tax preparers.  Around 60 percent of taxpayers use paid preparers and the IRS receives more than 10,000 complaints per year about bad actors. While the Justice […]

Wyden Statement at Finance Committee Hearing with IRS Commissioner Rettig

There are a few subjects I need to address today. First, oversight of the tax code. Last week the Chairman of the House Committee on Ways and Means exercised his authority under Section 6103 of the tax code to request six years of the president’s tax returns. I support his request completely. Chairman Neal raised […]

Wyden Statement on the Taxpayer First Act

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement on the Taxpayer First Act:  “Again and again in my service in the Senate I have battled the tax-preparation software industry to simplify filing taxes for the typical American. In fact, the industry spent millions and millions of dollars to fight my […]

Wyden: Big Pharma Refuses to Commit to Lower Prices, Action by Congress Needed

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today decried drug makers’ refusal to commit to lowering drug prices if middlemen rebate practices were changed. “In case there was any doubt, Big Pharma is not about to start self-policing their pricing practices,” Wyden said. “In order to prevent a cash grab that gives drug […]

Wyden Statement on OGE’s Refusal to Certify Mnuchin’s Financial Disclosure Report

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement on the status of Steven Mnuchin’s financial disclosure report: “I am concerned by the Office of Government Ethics’ refusal to certify Secretary Steven Mnuchin’s 2018 financial disclosure report. Before being confirmed by the Senate, he signed an ethics agreement that said he […]

Wyden Statement on Reports of Ways and Means Drug Pricing Markup

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement after news reports indicated the House Ways & Means Committee will be marking up drug pricing legislation including Wyden-initiated bills that address price gouging and secrecy in the drug pricing system: “I am pleased that the House is advancing my bills to bring […]